Advertisement

Psychiatric Quarterly

, Volume 90, Issue 4, pp 883–895 | Cite as

Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological Studies

  • Han Qi
  • Qian-Qian Zong
  • Grace K. I. Lok
  • Wen-Wang Rao
  • Feng-Rong An
  • Gabor S. Ungvari
  • Lloyd Balbuena
  • Qing-E ZhangEmail author
  • Yu-Tao XiangEmail author
Review Article
  • 66 Downloads

Abstract

Major depressive disorder (MDD) is a common psychiatric disorder in China, but its reported treatment rate varies largely across different studies. The objective of this meta-analysis was to determine the pooled treatment rate for people with MDD in China and its associated factors. Both English (PubMed, Cochrane Library, PsycINFO, Web of Science) and Chinese (Chinese National Knowledge Infrastructure, WanFang and SinoMed) databases were searched from their commencement date to November 13, 2018. Epidemiological studies that reported the treatment rate of MDD were included and synthesized using a random effects model. Fifteen studies covering 609,054 participants were included. The pooled treatment rate for MDD in China was 19.5% (95% CI: 10.7%–28.4%). Among the 15 studies, 9 reported the number of patients who received treatments in psychiatric hospitals with a pooled treatment rate of 5.2% (95% CI: 2.8%–7.5%). Meta-regression found that study quality (β = 0.131, P = 0.028) and male gender (β = 0.006, P = 0.039) were significantly associated with a higher treatment rate for MDD. In China, the treatment rate for MDD, particularly in psychiatric hospitals, was low. Effective public education and increasing access to mental health services will probably increase the number of people seeking and receiving treatment.

Keywords

Major depressive disorder Treatment rate Meta-analysis China 

Notes

Acknowledgements

The study was supported by the University of Macau (MYRG2015-00230-FHS; MYRG2016-00005-FHS), the National Key Research & Development Program of China (No. 2016YFC1307200), the Beijing Municipal Administration of Hospitals Incubating Program (No. PX2016028) and the Beijing Municipal Administration of Hospitals’ Ascent Plan (No. DFL20151801).

Compliance with Ethical Standards

Conflict of Interest

The authors have no conflicts of interest concerning this article.

Human and Animal Rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

NA.

Supplementary material

11126_2019_9666_Fig4_ESM.png (654 kb)
Supplementary Figure 1

Funnel plot of the 15 studies reporting treatment rate of MDD (PNG 654 kb)

11126_2019_9666_MOESM1_ESM.tif (33.9 mb)
High Resolution Image (TIF 34756 kb)
11126_2019_9666_Fig5_ESM.png (946 kb)
Supplementary Figure 2

Sensitivity analysis of the 15 studies reporting treatment rate of MDD (PNG 946 kb)

11126_2019_9666_MOESM2_ESM.tif (37.4 mb)
High Resolution Image (TIF 38272 kb)

References

  1. 1.
    Ferrari A, Somerville A, Baxter A, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476–93.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Kleinman A. Culture and depression. N Engl J Med. 2004;351(10):951–3.PubMedGoogle Scholar
  4. 4.
    Compton WM, Conway KP, Stinson FS, et al. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163(12):2141–7.PubMedGoogle Scholar
  5. 5.
    Zhong XM, Dong M, Wang F, et al. Physical comorbidities in older adults receiving antidepressants in Asia. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society. 2018;18(5):351–6.Google Scholar
  6. 6.
    Phillips MR, Liu H, Zhang Y. Suicide and social change in China. Cult Med Psychiatry. 1999;23(1):25–50.PubMedGoogle Scholar
  7. 7.
    Lee S, Tsang A, Zhang MY, et al. Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China. Psychol Med. 2007;37(1):61–71.PubMedGoogle Scholar
  8. 8.
    Gu L, Xie J, Long J, et al. Epidemiology of major depressive disorder in mainland China: a systematic review. PLoS One. 2013;8(6):e65356.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Fröjd SA, Nissinen ES, Pelkonen MU, et al. Depression and school performance in middle adolescent boys and girls. J Adolesc. 2008;31(4):485–98.PubMedGoogle Scholar
  10. 10.
    Buysse DJ, Angst J, Gamma A, et al. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Lynch FL, Clarke GN. Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006;31(6):143–51.Google Scholar
  12. 12.
    Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74(Pt B):277–86.PubMedGoogle Scholar
  13. 13.
    Kendler KS, Gardner CO, Fiske A, et al. Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry. 2009;66(8):857–63.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Cassano GB, Rucci P, Frank E, et al. The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry. 2004;161(7):1264–9.PubMedGoogle Scholar
  15. 15.
    Karyotaki E, Smit Y, Holdt Henningsen K, et al. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. J Affect Disord. 2016;194:144–52.PubMedGoogle Scholar
  16. 16.
    Bijl RV, de Graaf R, Hiripi E, et al. The prevalence of treated and untreated mental disorders in five countries. Health affairs (Project Hope). 2003;22(3):122–33.Google Scholar
  17. 17.
    Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA. 2004;291(21):2581–90.PubMedGoogle Scholar
  18. 18.
    Olfson M, Blanco C, Marcus SC. Treatment of adult depression in the United States. JAMA Intern Med. 2016;176(10):1482–91.PubMedGoogle Scholar
  19. 19.
    Yu C, Lyu J, Chen Y, et al. Epidemiology of major depressive episodes among Chinese adults aged 30–79 years: data from the China Kadoorie Biobank (in Chinese). ZHLXBXZZ. 2015;36(1):52–6.Google Scholar
  20. 20.
    Liu XJ, Zhou Y, Dong L, et al. A survey of major depression among elderly population in Wuhan (in Chinese). Chin Ment Health J. 2017;11:851–6.Google Scholar
  21. 21.
    Chin WY, Chan KT, Lam CL, et al. Help-seeking intentions and subsequent 12-month mental health service use in Chinese primary care patients with depressive symptoms. BMJ Open. 2015;5(1):e006730.PubMedCentralGoogle Scholar
  22. 22.
    Liang D, Mays VM, Hwang WC. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan. 2018;33(1):107–22.PubMedGoogle Scholar
  23. 23.
    Desai HD, Jann MW. Major depression in women: a review of the literature. J Am Pharm Assoc (Wash). 2000;40(4):525–37.Google Scholar
  24. 24.
    Chen Y, Bennett D, Clarke R, et al. Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women. Psychol Med. 2017;47(5):958–70.PubMedGoogle Scholar
  25. 25.
    Shidhaye R, Mendenhall E, Sumathipala K, et al. Association of somatoform disorders with anxiety and depression in women in low and middle income countries: a systematic review. Int Rev Psychiatry. 2013;25(1):65–76.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Guo J, Liu C, Wang X, et al. Relationships between depression, pain and sleep quality with doctor visits among community-based adults in north-West China. Public Health. 2017;147:30–8.PubMedGoogle Scholar
  27. 27.
    Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123–30.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1(2):37–9.Google Scholar
  29. 29.
    Pringsheim T, Jette N, Frolkis A, et al. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583–90.PubMedGoogle Scholar
  30. 30.
    Loney PL, Chambers LW, Bennett KJ, et al. Critical appraisal of the health research literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19(4):170–6.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Ibrahim AK, Kelly SJ, Adams CE, et al. A systematic review of studies of depression prevalence in university students. J Psychiatr Res. 2013;47(3):391–400.PubMedGoogle Scholar
  32. 32.
    Parker G, Beresford B, Clarke S, et al. Technical report for SCIE research review on the prevalence and incidence of parental mental health problems and the detection, screening and reporting of parental mental health problems. University of York: Social Policy Research Unit; 2008.Google Scholar
  33. 33.
    Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Rotenstein LS, Ramos MA, Torre M, et al. Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. Jama. 2016;316(21):2214–36.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Zhang ZZ. Evolution and Evaluation of the Chinese Economic Regions Division(in Chinese). Journal of Shanxi University of Finance and Economics(Higher Education Edition). 2010;13(02):89–92.Google Scholar
  36. 36.
    Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Jie R, Wang GP, Ding ZJ, et al. Investigation of major depression disorder in the people over 60 years old in Tianshui (in Chinese). Int J Geriatr. 2017;38(6):259–62.Google Scholar
  38. 38.
    Ou QM, Deng SL, Zhai WG. Epidemiological investigation and efficacy analysis of the influencing factors of depression in Huizhou, Guangdong province in 2015 (in Chinese). Modern Diagnosis and Treatment. 2016;11:2066–8.Google Scholar
  39. 39.
    Gupta S, Goren A, Dong P, et al. Prevalence, awareness, and burden of major depressive disorder in urban China. Expert Rev Pharmacoecon Outcomes Res. 2016;16(3):393–407.PubMedGoogle Scholar
  40. 40.
    Peng J, Sun D, Song Y. Investigation on the treatment rates of depression in Mudanjiang city. China Journal of Modern Medicine (in Chinese). 2013;23(5):108–10.Google Scholar
  41. 41.
    Ye MJ, Zhong SZ, Lin CY, et al. Prevalence, influencing factors and help-seeking style of depression among elderly population in Wenzhou area (in Chinese). Chin J Public Health. 2013;29(01):8–11.Google Scholar
  42. 42.
    Sun XR, Qu ZF, Jiang Q, et al. Investigation the epidemiology of senile depression in community of Pudong New Area, Shanghai (in Chinese). Medical Journal of Chinese People's Health. 2011;23(9):1078–1080,1119.Google Scholar
  43. 43.
    Duan WD, Liu TB, Hu CY, et al. Cross-sectional survey of depressive disorder in Shenzhen City in 2005 (in Chinese). Chinese Journal of Psychiatry. 2010;43(4):211–6.Google Scholar
  44. 44.
    Gui LH, Epidemiology Study on Depression among Rural Residents in Liuyang (in Chinese). 2010, Central South University.Google Scholar
  45. 45.
    Ma X, Xiang YT, Cai ZJ, et al. Prevalence and socio-demographic correlates of major depressive episode in rural and urban areas of Beijing. China Journal of Affective Disorders. 2009;115(3):323–30.PubMedGoogle Scholar
  46. 46.
    Lee S, Tsang A, Huang YQ, et al. The epidemiology of depression in metropolitan China. Psychol Med. 2009;39(5):735–47.PubMedGoogle Scholar
  47. 47.
    Ma X, Xiang YT, Li SR, et al. Prevalence and sociodemographic correlates of depression in an elderly population living with family members in Beijing, China. Psychol Med. 2008;38(12):1723–30.PubMedGoogle Scholar
  48. 48.
    Cui LJ, Su KQ, Jiang QP, et al. The prevalence of major depression disorders in Hebei Province from 2004 to 2005 (in Chinese). Chinese Journal of Psychiatry. 2007;40(03):140–3.Google Scholar
  49. 49.
    Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet (London, England). 2009;373(9680):2041–53.Google Scholar
  50. 50.
    Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet (London, England). 2007;370(9590):841–50.Google Scholar
  51. 51.
    Xiang YT, Ng CH, Yu X, et al. Rethinking progress and challenges of mental health care in China. World Psychiatry. 2018;17(2):231–2.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Xiang YT, Yu X, Ungvari GS, et al. China's National Mental Health law: a 26-year work in progress. Lancet. 2012;379(9818):780–2.PubMedGoogle Scholar
  53. 53.
    Phillips MR. Can China's new mental health law substantially reduce the burden of illness attributable to mental disorders? Lancet (London, England). 2013;381(9882):1964–6.Google Scholar
  54. 54.
    Tsang HW, Angell B, Corrigan PW, et al. A cross-cultural study of employers' concerns about hiring people with psychotic disorder: implications for recovery. Soc Psychiatry Psychiatr Epidemiol. 2007;42(9):723–33.Google Scholar
  55. 55.
    Cole MG, Yaffe MJ. Pathway to psychiatric care of the elderly with depression. Int J Geriatr Psychiatry. 1996;11(2):157–61.Google Scholar
  56. 56.
    Lee S, Tsang A, Kwok K. Twelve-month prevalence, correlates, and treatment preference of adults with DSM-IV major depressive episode in Hong Kong. J Affect Disord. 2007;98(1–2):129–36.PubMedGoogle Scholar
  57. 57.
    Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO world mental health survey initiative. Depress Anxiety. 2010;27(4):351–64.PubMedCentralGoogle Scholar
  58. 58.
    Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003;289(23):3095–105.PubMedGoogle Scholar
  59. 59.
    Pedrelli P, Borsari B, Lipson SK, et al. Gender differences in the relationships among major depressive disorder, heavy alcohol use, and mental health treatment engagement among college students. J Stud Alcohol Drugs. 2016;77(4):620–8.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Chen F. A modern interpretation of "the domestic wife and social husband". Journal of Yuxi Teachers College. 2003;12:18–21.Google Scholar
  61. 61.
    Winsper C, Ganapathy R, Marwaha S, et al. A systematic review and meta-regression analysis of aggression during the first episode of psychosis. Acta Psychiatr Scand. 2013;128(6):413–21.PubMedGoogle Scholar
  62. 62.
    Long J, Huang G, Liang W, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand. 2014;130(4):244–56.PubMedGoogle Scholar
  63. 63.
    Li Y, Cao XL, Zhong BL, et al. Smoking in male patients with schizophrenia in China: a meta-analysis. Drug Alcohol Depend. 2016;162:146–53.PubMedGoogle Scholar
  64. 64.
    Mata DA, Ramos MA, Bansal N, et al. Prevalence of depression and depressive symptoms among resident physicians: a systematic review and meta-analysis. JAMA. 2015;314(22):2373–83.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Han Qi
    • 1
  • Qian-Qian Zong
    • 2
  • Grace K. I. Lok
    • 3
  • Wen-Wang Rao
    • 3
  • Feng-Rong An
    • 1
  • Gabor S. Ungvari
    • 4
    • 5
  • Lloyd Balbuena
    • 6
  • Qing-E Zhang
    • 1
    Email author
  • Yu-Tao Xiang
    • 3
    Email author
  1. 1.The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital & the Advanced Innovation Center for Human Brain ProtectionCapital Medical UniversityBeijingChina
  2. 2.School of NursingCapital Medical UniversityBeijingChina
  3. 3.Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health SciencesUniversity of MacauMacao SARChina
  4. 4.The University of Notre Dame AustraliaFremantleAustralia
  5. 5.Division of Psychiatry, School of MedicineUniversity of Western AustraliaPerthAustralia
  6. 6.Department of PsychiatryUniversity of SaskatchewanSaskatoonCanada

Personalised recommendations